54 SPXIQ

MRK Merck & Co., Inc.

Healthcare · Drug Manufacturers - General

$123.06 +3.4% upside
Mean Target
$127.18
Consensus
1.9 - Buy
Analysts
28
Rank
#189 / 499
Upside Rank
#378
Analyst Price Target Distribution
$100
Low
$131
Median
$127
Mean
$150
High
Current $123
Mean $127
Median $131
99 estimates
Consensus
1.9 - Buy
52-Wk Low
$73.31
52-Wk High
$125.14
50-Day Avg
$112.09
Recent Analyst Ratings
FirmRatingTargetPriorDate
RBC Capital Outperform $142 — 2026-02-25
Barclays Overweight $140 — 2026-02-20
Guggenheim Buy $140 $122 2026-02-06
Citigroup Neutral $120 $115 2026-02-04
Cantor Fitzgerald Neutral $120 $116 2026-02-04
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC